TRACON Pharmaceuticals, Inc. Stock News
$0.04
40.98%
yesterday
Nasdaq,
Nov 15, 09:41 pm CET
TRACON Pharmaceuticals, Inc. Stock News
Neutral
GlobeNewsWire
●
4 months ago
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special meeting of the board of directors.
Neutral
GlobeNewsWire
●
5 months ago
Publication Highlights Activity of the Combination of TRC102 and Temodar (Temozolomide) in Patients who Progressed Following Initial Treatment with Surgical Resection, Temodar and External Beam Radiotherapy
Neutral
Seeking Alpha
●
6 months ago
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q1 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Charles Theuer - President & CEO Scott Brown - CFO Conference Call Participants Matthew Venezia - Alliance Global Partners Operator Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all callers ar...
Neutral
GlobeNewsWire
●
6 months ago
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, today announced financial results for the first quarter ended March 31, 2024. Th...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
